View Older Stories

Jul 27, 2015 09:35AM Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)

Apr 21, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 4/21: (GS) (TEVA) (INO) (TWTR)

Mar 18, 2015 10:00AM Notable Mergers and Acquisitions 3/18: (TEVA)/(RXDX) (MSCC)/(VTSS) (MGLN)

Apr 16, 2014 10:38AM Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded

Jan 21, 2014 09:34AM Pre-Open Stock Movers 1/21: (HEB) (YRCW) (DOW) Higher; (AMRN) (PATH) (DB) Lower (more...)

Jan 8, 2014 09:32AM Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)

Dec 27, 2013 09:29AM Pre-Open Stock Movers 12/27: (WPCS) (ANIP) (FE) Higher; (TWTR) (PTRY) (BBRY) Lower (more...)

Aug 5, 2013 10:52AM Notable Analyst Rating Changes 08/05: (RVBD) (WFM) (BRCM) Upgraded; (CB) (QCOM) (KRFT) Downgraded

Aug 5, 2013 09:40AM Pre-Open Stock Movers 8/5: (CGEN) (VRNG) (TSN) Higher; (FOSL) (CBOE) (QCOM) Lower (more...)

Sep 10, 2012 08:46AM Needham & Company Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Getting Some Mojo Back

Sep 10, 2012 08:43AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty

Aug 24, 2012 08:05AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'

Aug 3, 2012 09:45AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink

Jul 20, 2012 08:31AM Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo

May 30, 2012 07:36AM Needham & Company maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Defending Core Fundamentals Despite Setback From Lovaza Litigation

May 25, 2012 07:55AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); Adjusting Estimates

May 23, 2012 10:50AM Notable Analyst Rating Changes 05/23: (SBUX) (AMAT) (WMB) Upgraded; (NDAQ) (PSO) (ARBA) Downgraded

May 10, 2012 08:32AM Needham & Company Upgrades Teva Pharma (TEVA) to Hold; Same Old Growth Drags and Risk Overhangs

Feb 16, 2012 08:57AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Momentum Carry-Over into 2012 Could Provide Upside to Current Expectations

Dec 22, 2011 07:51AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Revamped Financial Guidance Largely In-Line; 2012 Will Be A Year of Slugging It Out

Nov 3, 2011 08:38AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); 3Q11 Results Only A Mother Could Love; We’ll Play Through The Pain

Oct 19, 2011 08:27AM Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Confirms Purchase of Divested Teva-Cephalon Products for Bargain Price

Oct 10, 2011 08:06AM Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Positive Outcome for Par as a Result of Teva-Cephalon Merger

Aug 26, 2011 07:30AM Teva (TEVA) May Be One of the Cheapest Pharmas Right Now - Barron's

Aug 19, 2011 08:34AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); To Be the Man, You Have to Beat the Man

Jul 28, 2011 07:43AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Strong Global Growth Leads 2Q11 “Beat” Despite Continuing U.S. Malaise

Jul 25, 2011 08:38AM Needham & Company Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Inequitable Conduct Concluding Arguments; Proof-of-intent Hurdle Considerable

Apr 19, 2011 10:44AM Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded

Apr 15, 2011 08:07AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); U.S. and International Cubicin Sales Beat Expectations

Apr 14, 2011 07:54AM Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); TEVA Comes Through With Allegra OTC Approval, “In Numbers” but Should Provide Additional Fuel

Apr 12, 2011 07:35AM Needham & Company on Teva Pharma (TEVA): Weakness Unwarranted As Laquinimod Efficacy Metrics Largely In Line With Softened Expectations Headed Into AAN Meeting

Apr 5, 2011 09:10AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Teva and Cubist Settle Cubicin Litigation

Mar 28, 2011 08:32AM Needham & Company on Teva Pharma (TEVA): Potential Near-Term Pivot Points Could Bump Up Short-Term Volatility; Underlying Fundamentals Unchanged

Feb 9, 2011 08:40AM Needham & Company maintains a 'Strong Buy' on Teva Pharma (TEVA); No Longer Plug & Play Generic Name Though Reward/Risk Remains Firmly Compelling

Dec 13, 2010 08:57AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Copaxone Citizen Petition Round Three Now Underway

Nov 30, 2010 01:28PM Needham & Company on Impax Labs (IPXL); Lawsuit Appears to Confirm That Generic Concerta Opportunity Remains A Real But Distant Star On Horizon

Nov 3, 2010 10:27AM Needham & Company on Teva Pharma (TEVA): If It Were Only As Easy As the Numbers; 3Q10 Results Impressive Though Shares Remain Overly

Jul 28, 2010 08:13AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Like Current Reward-to-Risk

Jun 30, 2010 07:47AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Generic Effexor XR Approval As Expected - Longer Exclusivity Shelf Life Could Boost 2011

Jun 2, 2010 10:55AM Notable Analyst Rating Changes 06/02: JOYG, JPM, MON, JBL Upgraded; CA, ARST, HI, EXC Downgraded

Jun 2, 2010 07:47AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Blitzkrieg Bops Bayer’s Yaz With Generic Launch

Feb 17, 2010 08:35AM Needham & Company Lifts Target on Teva (TEVA) to $63

Sep 25, 2008 07:55AM Needham & Co Initiates Coverage on Drugs - Generic

View Older Stories